Estrogen receptor-beta status influences clinical outcome of triple-negative breast cancer.
In this conference paper, we show that estrogen receptor-beta status influences clinical outcome of triple-negative breast cancer referring two of our recent research articles.
Sakamoto
Goi
G
Sakamoto Memorial Clinic, Academy of Breast Pathology, 2-1-3 Ichigaya Tamachi, Shinjuku-ku, Tokyo 162-0843, Japan.
Honma
Naoko
N
D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D047629:Estrogen Receptor beta / Q000378:metabolism*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*; D016896:Treatment Outcome
D047629:Estrogen Receptor beta; D018719:Erb-b2 Receptor Tyrosine Kinases; D011980:Receptors, Progesterone